DERMAGIC EXPRESS / Dermatologia y Bibliografia - Dermatology & bibliography: ivermectina escabiosis y Sars-Cov2 DERMAGIC EXPRESS / Dermatologia y Bibliografia - Dermatology & bibliography: ivermectina escabiosis y Sars-Cov2
Mostrando entradas con la etiqueta ivermectina escabiosis y Sars-Cov2. Mostrar todas las entradas
Mostrando entradas con la etiqueta ivermectina escabiosis y Sars-Cov2. Mostrar todas las entradas

viernes, 2 de agosto de 2024

THE IVERMECTIN, SCABIES AND SARS-COV2 / EL IVERMECTIN , SARNA Y SARS-COV2


The Ivermectin the Scabies and Sars-Cov2 !


El ivermectin la SARNA o escabiosis y el virus Sars-Cov2!


La ivermectina, escabiosis y sars-cov2




EDITORIAL ENGLISH
===================
 

Hello DERMAGIC friends, IVERMECTIN is an anti parasitic and anti inflammatory drug widely used in diseases such as the cutaneous  larva Migrans, Strongyloidiasis, Onchocerciasis, filariasis (bancroftiasis), pediculosis capitis (lice) Scabies, and lately approved its use for the treatment of The rosacea. Presentation of the product: Tablets, lotion, shampoo, cream at 1%, and and injections for systemic use in animals.


Due to the increase of scabies in an epidemic form in some countries and the absence of lindane due to its proven toxicity, ivermectin has been available as a treatment for it. In these bibliographical references, you will be able to find out about the uses of this drug, in SCABIES and other pathologies. At the end a monograph of the product.


The dose is calculated at 150 - 250 Micrograms per kilo weight, if we calculate it to 100 micrograms per kilo weight in an adult of 60 kgs, would be 6,000 mcg that would be 6 mgrs, that is to say a tablet of 6 mgrs of IVERMECTIN or 2 tables of 3 mgs.


Its results for many Scientists and doctors, others combine it with topical treatments like sulfur lotions and or Crotamiton.


THE IVERMECTIN AND Sars-Cov.2


Following the emergence of the pandemic in 2020, reports began to appear that IVERMECTIN was and is effective against the Sars-Cov2 virus or COVID-19, and the European Parliament on December 10, 2023 declared the following:

"The drug ivermectin, on the other hand, has been studied in 99 of 137,000 patients under the direction of 1,089 scientists, with a prevention success rate of 85% and an early treatment success rate of 62%, and was launched in 2019 approved for the early treatment of COVID-19. " (reference 24)

Some studies have shown that the drug is ineffective, usually at doses that are too high or too low. In addition to ivermectin, there are other treatments that are safe, effective and inexpensive.

The FDA today 2024 has not approved its use for the treatment of this virus, claiming that it is ineffective.

Greetings to all

Dr. José Lapenta, 

Dr. José  M Lapenta



 
EDITORIAL ESPAÑOL
======================= 
Hola amigos DERMAGICOS , el IVERMECTIN es una droga anti parasitaria y anti inflamatoria ampliamente utilizada en enfermedades como la larva Migrans cutánea, Estrongiloidiasis, Oncocercosis, filariasis (bancroftiasis), pediculosis capitis (piojos) Escabiosis, y últimamente se aprobó su uso para el tratamiento de la rosácea. La presentación del producto: Tabletas, loción, champú, crema al 1% e inyección para uso sistémico en animales.  

Ante la epidemia de SARNA o escabiosis que se presenta en algunos paises y la ausencia del Lindano por su probada toxicidad, el ivermectin se ha polarizado como tratamiento para la misma. En estas referencias bibliográficas, podrás enterarte de los usos de esta droga, en la SARNA O ESCABIOSIS y otras patologías. Al final una Monografía del producto. 

Para el tratamiento de la SARNA o ESCABIOSIS La dosis se calcula a 150 - 250 Microgramos por kilo peso, si la calculamos a 100 microgramos por kilo peso en un adulto de 60 kgs, serian 6.000 mcg que vendrían siendo 6 mgrs, es decir una tableta de 6 mgrs de ivermectina o 2 de 3 mgrs.  

Sus resultados para muchos científicos y doctores es efectivo, otros la combinan con otros tratamientos típicos como lociones azufradas y o Crotamiton.

                                                           

 IVERMECTINA Y Sars-COV2


A raíz de la aparición de la pandemia en el año 2020, comenzaron a aparecer reportes de que la IVERMECTINA era y es eficaz contra el virus Sars-Cov2 o COVID-19, y el parlamento Europeo el 10 de Diciembre del 2023 declaro lo siguiente:

" El medicamento ivermectina, por otro lado, se ha estudiado en 99 de 137.000 pacientes bajo la dirección de 1.089 científicos, con una tasa de éxito en la prevención del 85% y una tasa de éxito en el tratamiento temprano del 62%, y se lanzó en 2019 aprobado para el tratamiento temprano de COVID-19. "

Algunos estudios han demostrado que el fármaco es ineficaz, generalmente en dosis demasiado altas o demasiado bajas. Además de la ivermectina, existen otros tratamientos que son seguros, eficaces y económicos. (referencia 24)

La FDA hoy día 2024 no ha aprobado su uso para el tratamiento de este virus, alegando que es ineficaz.


Saludos a todos,,, 

Dr. José Lapenta.
Dr. José  M Lapenta
  
================================================================
REFERENCIAS BIBLIOGRAFICAS / BIBLIOGRAPHICAL REFERENCES
================================================================
1.) The treatment of scabies with ivermectin.
2.) Comparison of ivermectin and benzyl benzoate for treatment of scabies.
3.) Successful use of ivermectin in the treatment of endemic scabies in a nursing home.
4.) Treatment of HIV-related scabies with emphasis on the efficacy of ivermectin.
5.) Ivermectin-responsive crusted scabies in HTLV1 carrier.
6.) Crusted ("Norwegian") scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission [see comments]
7.) Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin.
8.) Ivermectin for Sarcoptes scabiei hyperinfestation.
9.) Topical application of ivermectin for human ectoparasites.
10.) An assessment of topical and oral prescription and over-the-counter treatments for head lice.
11.) Efficacy of ivermectin for the treatment of head lice (Pediculosis capitis).
12.) Physiology, pharmacology and parasitology.
13.) Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS.
14.) Efficacy of ivermectin against Strongyloides stercoralis in humans.
15.) Efficacy of ivermectin in the therapy of cutaneous larva migrans [letter]
16.) Ivermectin 1% Cream (Soolantra) for Inflammatory Lesions of Rosacea.
17.) of rosacea with topical ivermectin cream: a series of 34 cases.
18.)The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis.
19.) The efficacy of topical and oral ivermectin in the treatment of human scabies.
20.) Assessment of oral ivermectin versus shampoo in the treatment of pediculosis (head lice infestation) in rural areas of Sine-Saloum, Senegal.
21.) Head lice probably resistant to ivermectin recovered from two rural girls in Dielmo, a village in Sine-Saloum, Senegal.
22.) Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications.
23.) IVERMECTIN TABLETS MONOGRAPH
24.) Approval of ivermectin for COVID-19 treatment

================================================================

Si Te ha gustado, Compartelo